Format
Sort by
Items per page

Send to

Choose Destination

Links from Gene

Items: 1 to 20 of 126

1.

Genetic substrates of psychosis in patients with Parkinson's disease: A critical review.

Lenka A, Arumugham SS, Christopher R, Pal PK.

J Neurol Sci. 2016 May 15;364:33-41. doi: 10.1016/j.jns.2016.03.005. Epub 2016 Mar 3. Review.

PMID:
27084212
2.

Cholecystokinin in plasma predicts cardiovascular mortality in elderly females.

Goetze JP, Rehfeld JF, Alehagen U.

Int J Cardiol. 2016 Apr 15;209:37-41. doi: 10.1016/j.ijcard.2016.02.038. Epub 2016 Feb 3.

PMID:
26878472
3.

Exploring the association between a cholecystokinin promoter polymorphism (rs1799923) and posttraumatic stress disorder in combat veterans.

Badour CL, Hirsch RL, Zhang J, Mandel H, Hamner M, Wang Z.

J Anxiety Disord. 2015 Dec;36:78-83. doi: 10.1016/j.janxdis.2015.09.009. Epub 2015 Sep 28.

PMID:
26454231
4.

Postprandial profiles of CCK after high fat and high carbohydrate meals and the relationship to satiety in humans.

Gibbons C, Finlayson G, Caudwell P, Webb DL, Hellström PM, Näslund E, Blundell JE.

Peptides. 2016 Mar;77:3-8. doi: 10.1016/j.peptides.2015.09.010. Epub 2015 Sep 30.

5.

Disturbed release of cholecystokinin in pregnant women with hyperemesis gravidarum.

Biberoglu E, Kirbas A, Iskender C, Dirican A, Daglar H, Demirtas C, Doganay B, Uygur D, Biberoglu K.

J Obstet Gynaecol Res. 2015 Apr;41(4):505-11. doi: 10.1111/jog.12562. Epub 2014 Oct 20.

PMID:
25331205
6.

Functional dyspepsia patients have lower mucosal cholecystokinin concentrations in response to duodenal lipid.

van Boxel OS, ter Linde JJ, Oors J, Otto B, Weusten BL, Feinle-Bisset C, Smout AJ, Siersema PD.

Eur J Gastroenterol Hepatol. 2014 Feb;26(2):205-12. doi: 10.1097/MEG.0000000000000001.

PMID:
24252886
7.

The effect of submicron fat droplets in a drink on satiety, food intake, and cholecystokinin in healthy volunteers.

Peters HP, Bouwens EC, Schuring EA, Haddeman E, Velikov KP, Melnikov SM.

Eur J Nutr. 2014 Apr;53(3):723-9. doi: 10.1007/s00394-013-0576-9. Epub 2013 Aug 23.

PMID:
23975326
8.

An important role for cholecystokinin, a CLOCK target gene, in the development and treatment of manic-like behaviors.

Arey RN, Enwright JF 3rd, Spencer SM, Falcon E, Ozburn AR, Ghose S, Tamminga C, McClung CA.

Mol Psychiatry. 2014 Mar;19(3):342-50. doi: 10.1038/mp.2013.12. Epub 2013 Feb 12. Erratum in: Mol Psychiatry. 2014 Mar;19(3):400.

9.

Cholecystokinin revisited: CCK and the hunger trap in anorexia nervosa.

Cuntz U, Enck P, Frühauf E, Lehnert P, Riepl RL, Fichter MM, Otto B.

PLoS One. 2013;8(1):e54457. doi: 10.1371/journal.pone.0054457. Epub 2013 Jan 17.

10.

Regulating satiety in bulimia nervosa: the role of cholecystokinin.

Hannon-Engel S.

Perspect Psychiatr Care. 2012 Jan;48(1):34-40. doi: 10.1111/j.1744-6163.2011.00304.x. Epub 2011 Apr 13. Review.

11.

Unsulfated cholecystokinin: An overlooked hormone?

Rehfeld JF, Agersnap M.

Regul Pept. 2012 Jan 10;173(1-3):1-5. doi: 10.1016/j.regpep.2011.09.009. Epub 2011 Oct 8. Review.

PMID:
21985915
12.

[Relationship between cholecystokinin gene -45C/T polymorphism and schizophrenia and its application in forensic medicine].

Yang J, Ding M, Sun Y, Pang H, Xing JX, Xuan JF, Li CM, Wang BJ.

Fa Yi Xue Za Zhi. 2011 Feb;27(1):22-4. Chinese.

PMID:
21542221
13.

Racial differences may influence the role of cholecystokinin polymorphisms in Parkinson's disease hallucinations.

Goldman JG, Marr D, Zhou L, Ouyang B, Leurgans SE, Berry-Kravis E, Goetz CG.

Mov Disord. 2011 Aug 1;26(9):1781-2. doi: 10.1002/mds.23655. Epub 2011 Apr 19. No abstract available.

14.

Cholecystokinin: a multi-functional molecular switch of neuronal circuits.

Lee SY, Soltesz I.

Dev Neurobiol. 2011 Jan 1;71(1):83-91. doi: 10.1002/dneu.20815. Review.

15.

Cholecystokinin in plasma and cerebrospinal fluid--a study in healthy young women.

Lundberg K, Hilke S, Nordin C, Theodorsson E, Josefsson A.

Peptides. 2010 Aug;31(8):1625-8. doi: 10.1016/j.peptides.2010.04.028. Epub 2010 May 8.

PMID:
20457200
16.

Cholecystokinin: role in thermoregulation and other aspects of energetics.

Szelényi Z.

Clin Chim Acta. 2010 Mar;411(5-6):329-35. doi: 10.1016/j.cca.2009.12.016. Epub 2009 Dec 28. Review.

PMID:
20036221
17.

Effects of cefaclor on gastric emptying and cholecystokinin release in healthy humans.

Ma J, Bellon M, Wishart JM, Young RL, Jones KL, Horowitz M, Rayner CK.

Regul Pept. 2010 Jan 8;159(1-3):156-9. doi: 10.1016/j.regpep.2009.11.009.

PMID:
19914303
18.

Asynchronous transmitter release from cholecystokinin-containing inhibitory interneurons is widespread and target-cell independent.

Daw MI, Tricoire L, Erdelyi F, Szabo G, McBain CJ.

J Neurosci. 2009 Sep 9;29(36):11112-22. doi: 10.1523/JNEUROSCI.5760-08.2009.

19.

Direct activation of cytosolic Ca2+ signaling and enzyme secretion by cholecystokinin in human pancreatic acinar cells.

Murphy JA, Criddle DN, Sherwood M, Chvanov M, Mukherjee R, McLaughlin E, Booth D, Gerasimenko JV, Raraty MG, Ghaneh P, Neoptolemos JP, Gerasimenko OV, Tepikin AV, Green GM, Reeve JR Jr, Petersen OH, Sutton R.

Gastroenterology. 2008 Aug;135(2):632-41. doi: 10.1053/j.gastro.2008.05.026. Epub 2008 May 7.

PMID:
18555802
20.

Cholecystokinin (CCK) and CCK receptor expression by human gliomas: Evidence for an autocrine/paracrine stimulatory loop.

Oikonomou E, Buchfelder M, Adams EF.

Neuropeptides. 2008 Jun;42(3):255-65. doi: 10.1016/j.npep.2008.02.005.

PMID:
18423848

Supplemental Content

Support Center